- Home
- ATLX vs NSPR Comparison
ATLX vs NSPR Comparison
Compare ATLX & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLX
- NSPR
- Stock Information
- Founded
- ATLX 2011
- NSPR 2005
- Country
- ATLX Brazil
- NSPR United States
- Employees
- ATLX N/A
- NSPR N/A
- Industry
- ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- NSPR Medical/Dental Instruments
- Sector
- ATLX Industrials
- NSPR Health Care
- Exchange
- ATLX Nasdaq
- NSPR Nasdaq
- Market Cap
- ATLX 68.5M
- NSPR 75.1M
- IPO Year
- ATLX N/A
- NSPR N/A
- Fundamental
- Price
- ATLX $4.47
- NSPR $2.40
- Analyst Decision
- ATLX Strong Buy
- NSPR Strong Buy
- Analyst Count
- ATLX 2
- NSPR 2
- Target Price
- ATLX $22.25
- NSPR $4.50
- AVG Volume (30 Days)
- ATLX 301.5K
- NSPR 387.7K
- Earning Date
- ATLX 08-08-2025
- NSPR 08-05-2025
- Dividend Yield
- ATLX N/A
- NSPR N/A
- EPS Growth
- ATLX N/A
- NSPR N/A
- EPS
- ATLX N/A
- NSPR N/A
- Revenue
- ATLX $587,122.00
- NSPR $7,027,000.00
- Revenue This Year
- ATLX $19,668.81
- NSPR $4.85
- Revenue Next Year
- ATLX $43.15
- NSPR $113.47
- P/E Ratio
- ATLX N/A
- NSPR N/A
- Revenue Growth
- ATLX 214.46
- NSPR 8.49
- 52 Week Low
- ATLX $3.54
- NSPR $1.99
- 52 Week High
- ATLX $13.70
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- ATLX 66.08
- NSPR 52.10
- Support Level
- ATLX $3.80
- NSPR $2.27
- Resistance Level
- ATLX $4.25
- NSPR $2.45
- Average True Range (ATR)
- ATLX 0.25
- NSPR 0.12
- MACD
- ATLX 0.08
- NSPR 0.02
- Stochastic Oscillator
- ATLX 100.00
- NSPR 76.39
About ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.